Adjuvant chemotherapy is not associated with improved survival for all high‐risk factors in stage II colon cancer

Adjuvant chemotherapy can be considered in high‐risk stage II colon cancer comprising pT4, poor/undifferentiated grade, vascular invasion, emergency surgery and/or

Saved in:
Bibliographic Details
Published in:International journal of cancer 2016-07, Vol.139 (1), p.187-193
Main Authors: Verhoeff, S.R., van Erning, F.N., Lemmens, V.E.P.P., de Wilt, J.H.W., Pruijt, J.F.M.
Format: Article
Language:English
Subjects:
Adenocarcinoma - drug therapy
Adenocarcinoma - epidemiology
Adenocarcinoma - pathology
adjuvant chemotherapy
Adolescent
Adult
Aged
Aged, 80 and over
Cancer
Chemotherapy
Chemotherapy, Adjuvant
Clinical Trials as Topic
Colonic Neoplasms - drug therapy
Colonic Neoplasms - epidemiology
Colonic Neoplasms - pathology
Colorectal cancer
Disease-Free Survival
Drug dosages
Female
high‐risk stage II colon cancer
Humans
Kaplan-Meier Estimate
Lymph Nodes - pathology
Male
Medical research
Middle Aged
Mortality
Neoplasm Staging
overall survival
Patients
Prognosis
pT4
relative survival
Risk Factors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Adjuvant chemotherapy can be considered in high‐risk stage II colon cancer comprising pT4, poor/undifferentiated grade, vascular invasion, emergency surgery and/or
ISSN:0020-7136
1097-0215
DOI:10.1002/ijc.30053